Evidence map›Paper›PMID 25450007›Full record

ArticleCancer medicine2015

Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells.

Naoki Sato, Masao Maeda, Mai Sugiyama, Satoko Ito, Toshinori Hyodo, Akio Masuda, Nobuyuki Tsunoda, Toshio Kokuryo, Michinari Hamaguchi, Masato Nagino and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Research Progress on the Relationship Between PRPF8 and Cancer.Current issues in molecular biology · 2025
    Review
  12. Article
  13. Article
  14. Prognostic biomarkers based onTranslational cancer research · 2024
    Article
  15. Article
  16. Article
  17. Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Naoki SatoDepartment of Surgical Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, 466-8550, Japan.
Masao Maeda
Mai Sugiyama
Satoko Ito
Toshinori Hyodo
Akio Masuda
Nobuyuki Tsunoda
Toshio Kokuryo
Michinari Hamaguchi
Masato Nagino
Takeshi Senga
Nagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA splicing is a fundamental process for protein synthesis. Recent studies have reported that drugs that inhibit splicing have cytotoxic effects on various tumor cell lines. In this report, we demonstrate that depletion of SNW1, a component of the spliceosome, induces apoptosis in breast cancer cells. Proteomics and biochemical analyses revealed that SNW1 directly associates with other spliceosome components, including EFTUD2 (Snu114) and SNRNP200 (Brr2). The SKIP region of SNW1 interacted with the N-terminus of EFTUD2 as well as two independent regions in the C-terminus of SNRNP200. Similar to SNW1 depletion, knockdown of EFTUD2 increased the numbers of apoptotic cells. Furthermore, we demonstrate that exogenous expression of either the SKIP region of SNW1 or the N-terminus region of EFTUD2 significantly promoted cellular apoptosis. Our results suggest that the inhibition of SNW1 or its associating proteins may be a novel therapeutic strategy for cancer treatment.

Indexed as

ApoptosisBinding SitesBreast NeoplasmsCell Line, TumorCell ProliferationFemaleGene Knockdown TechniquesHEK293 CellsHumansMCF-7 CellsNuclear Receptor CoactivatorsPeptide Elongation FactorsProteomicsRibonucleoproteins, Small NuclearRibonucleoprotein, U5 Small NuclearSpliceosomesEFTUD2 protein, humanNuclear Receptor CoactivatorsPeptide Elongation FactorsRibonucleoproteins, Small NuclearRibonucleoprotein, U5 Small NuclearSNRNP200 protein, humanSNW1 protein, humanApoptosisEFTUD2PRPF8RNA splicingSNRNP200SNW1

Identifiers

PMID25450007
PMCPMC4329010
OpenAlexW1965333626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.